Trial intelligence / Profile preview

Safety of Varisolve in Varicose Vein Patients with Right-to-Left Shunt

NCT00442364Phase 2Completed

Sponsor
Boston Scientific Corporation
Start
Mar 2007
Primary completion
Jun 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of 10XB101 in Varicose Veins, sponsored by Boston Scientific Corporation. Started Mar 2007; status: completed.

02

Drugs

10XB101
03

Conditions

Varicose Veins

Beyond the preview

Go deeper on NCT00442364.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00442364.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call